2018
DOI: 10.33786/jcpr.2018.v08i02.004
|View full text |Cite
|
Sign up to set email alerts
|

A Review on Analysis of Dapagliflozin.

Abstract: Dapagliflozin is a sodium-glucose co transporter 2 inhibitor (SGLT2) as a new class of oral antidiabetic drugs. It is indicated for treatment of Diabetes mellitus type 2, either alone or in combination with other oral hypoglycaemic agents. The aim of this review is to focus on update of determination of Dapagliflozin in bulk and in pharmaceutical preparations using chromatographic and spectrophotometric methods. Dapagliflozin is estimated by RP-HPLC, UV, RP-UPLC, LC-MS methods. This review provides detailed in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 4 publications
0
0
0
Order By: Relevance